FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women
December 11, 2024 15:18 ET
|
FemPulse
SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II...
Global Urology Supplements Market Trends Analysis Report 2024-2030: Asia Pacific Emerges as Dominant Force, Multi-Ingredient Supplements Lead
April 30, 2024 05:36 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market Size, Share & Trends Analysis Report by Type (Multi-ingredient, Single Ingredient), Application (Urinary Tract...
EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB)
January 04, 2024 08:00 ET
|
EG 427
EG427 Announces New Preclinical Results from Multiple Studies of EG110A in Neurogenic Detrusor Overactivity (NDO) and Overactive Bladder (OAB) In a non-clinical pharmacology study in an OAB model,...
STIMVIA Unveils Innovative Solution to Transform CNS Disorder Treatments at TechCrunch Disrupt 2023
September 20, 2023 12:00 ET
|
STIMVIA s.r.o.
SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- STIMVIA, a pioneer medical technology company, introduces an effective non-invasive neuromodulation treatment, URIS®, addressing deep brain...
EG 427 announces final Series A closing, achieving €18 million in total funds raised
July 13, 2023 02:00 ET
|
EG 427
Paris, France, 13 July, 2023 – EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions, announces today the final closing of a Series A financing. EG 427 raised an...
Women’s Health Leader Elidah Launches Game-changing ELITONE URGE Device To Treat Overactive Bladder
May 02, 2023 08:00 ET
|
Elidah Inc.
MONROE, Conn., May 02, 2023 (GLOBE NEWSWIRE) -- Providing the same relief for overactive bladder (OAB) that they’ve become known for in the stress urinary incontinence arena, MedTech Elidah is...
Overactive Bladder Treatment Market to Hit USD 4.89 Billion by 2030 driven by the Growing Awareness about OAB and Availability of Advanced Diagnostic Tools | Research by SNS Insider
April 04, 2023 11:53 ET
|
SNS Insider pvt ltd
Pune, April 04, 2023 (GLOBE NEWSWIRE) -- As per the report from SNS Insider, the Overactive Bladder Treatment Market was assessed at USD 3.63 billion in 2022 and is projected to expand to USD 4.89...
Overactive Bladder Market to Grow Rapidly at a Considerable CAGR During the Forecast Period (2023–2032) | DelveInsight
March 28, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 28, 2023 (GLOBE NEWSWIRE) -- Overactive Bladder Market to Grow Rapidly at a Considerable CAGR During the Forecast Period (2023–2032) | DelveInsight The overactive bladder...
Global Overactive Bladder Market Landscape Report 2021-2025
February 03, 2022 04:58 ET
|
Research and Markets
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Market Spotlight: Overactive Bladder" report has been added to ResearchAndMarkets.com's offering. Overactive bladder is characterized by urinary...
First Patient in Florida Treated in Tampa in the OASIS Clinical Trial of the RENOVA iStim System for Overactive Bladder
October 20, 2020 08:50 ET
|
BlueWind Medical; Florida Urology Partners
TAMPA, Fla., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Overactive bladder or OAB, affects millions of women of all ages, and can negatively impact nearly every aspect of daily life—from work performance to...